Your browser doesn't support javascript.
loading
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study.
Haagsma, Juanita A; Charalampous, Periklis; Ariani, Filippo; Gallay, Anne; Moesgaard Iburg, Kim; Nena, Evangelia; Ngwa, Che Henry; Rommel, Alexander; Zelviene, Ausra; Abegaz, Kedir Hussein; Al Hamad, Hanadi; Albano, Luciana; Liliana Andrei, Catalina; Andrei, Tudorel; Antonazzo, Ippazio Cosimo; Aremu, Olatunde; Arumugam, Ashokan; Atreya, Alok; Aujayeb, Avinash; Ayuso-Mateos, Jose Luis; Engelbert Bain, Luchuo; Banach, Maciej; Winfried Bärnighausen, Till; Barone-Adesi, Francesco; Beghi, Massimiliano; Bennett, Derrick A; Bhagavathula, Akshaya S; Carvalho, Félix; Castelpietra, Giulio; Caterina, Ledda; Chandan, Joht Singh; Couto, Rosa A S; Cruz-Martins, Natália; Damiani, Giovanni; Dastiridou, Anna; Demetriades, Andreas K; Dias-da-Silva, Diana; Francis Fagbamigbe, Adeniyi; Fereshtehnejad, Seyed-Mohammad; Fernandes, Eduarda; Ferrara, Pietro; Fischer, Florian; Fra Paleo, Urbano; Ghirini, Silvia; Glasbey, James C; Glavan, Ionela-Roxana; Gomes, Nelson G M; Grivna, Michal; Harlianto, Netanja I; Haro, Josep Maria.
Afiliação
  • Haagsma JA; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Charalampous P; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. p.charalampous@erasmusmc.nl.
  • Ariani F; Epidemiology Unit, Central Tuscany Local Health Authority, Florence, Italy.
  • Gallay A; Department of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
  • Moesgaard Iburg K; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Nena E; Laboratory of Social Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
  • Ngwa CH; School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Rommel A; Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
  • Zelviene A; Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
  • Abegaz KH; Institute of Hygiene, Health Information Center, Kaunas, Lithuania.
  • Al Hamad H; Department of Biostatistics, Near East University, Nicosia, Cyprus.
  • Albano L; Department of Biostatistics and Health Informatics, Madda Walabu University, Bale Robe, Ethiopia.
  • Liliana Andrei C; Geriatrics and Long Term Care Department, Hamad Medical Corporation, Doha, Qatar.
  • Andrei T; Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Antonazzo IC; Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Aremu O; Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania.
  • Arumugam A; Research Center On Public Health, University of Milan-Bicocca, Monza, Italy.
  • Atreya A; Department of Public Health, Birmingham City University, Birmingham, UK.
  • Aujayeb A; Department of Physiotherapy, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
  • Ayuso-Mateos JL; Department of Forensic Medicine, Lumbini Medical College, Palpa, Nepal.
  • Engelbert Bain L; Northumbria Healthcare NHS Foundation Trust, Cramlington, UK.
  • Banach M; Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.
  • Winfried Bärnighausen T; Carlos III Health Institute, Biomedical Research Networking Center for Mental Health Network (CiberSAM), Madrid, Spain.
  • Barone-Adesi F; Lincoln International Institute for Rural Health (LIIRH), University of Lincoln, Lincoln, UK.
  • Beghi M; Global South Health Services and Research, GSHS, Amsterdam, The Netherlands.
  • Bennett DA; Department of Hypertension, Medical University of Lodz, Lodz, Poland.
  • Bhagavathula AS; Polish Mothers' Memorial Hospital Research Institute, Lodz, Poland.
  • Carvalho F; Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany.
  • Castelpietra G; T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Caterina L; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Chandan JS; Department of Mental Health, AUSL Romagna, Cesena, Italy.
  • Couto RAS; Clinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Cruz-Martins N; Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Damiani G; Department of Social and Clinical Pharmacy, Charles University, Hradec Kralova, Prague, Czech Republic.
  • Dastiridou A; Research Unit On Applied Molecular Biosciences (UCIBIO), University of Porto, Porto, Portugal.
  • Demetriades AK; Outpatient and Inpatient Care Service, Central Health Directorate, Friuli Venezia Giulia Region, Trieste, Italy.
  • Dias-da-Silva D; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Francis Fagbamigbe A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Fereshtehnejad SM; Department of Chemical Sciences, University of Porto, Porto, Portugal.
  • Fernandes E; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Ferrara P; Institute for Research & Innovation in Health (i3S), University of Porto, Porto, Portugal.
  • Fischer F; Institute of Research and Advanced, Training in Health Sciences and Technologies (INFACTS), Gandra, Portugal.
  • Fra Paleo U; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy.
  • Ghirini S; Department of Dermatology, Case Western Reserve University, Cleveland, OH, USA.
  • Glasbey JC; Department of Ophthalmology, University Hospital of Larissa, Larissa, Greece.
  • Glavan IR; Edinburgh Spinal Surgery Outcome Studies Group, Department of Neurosurgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Gomes NGM; Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • Grivna M; Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Harlianto NI; Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Haro JM; Division of Clinical Geriatrics, Department of Neurobiology, Karolinska Institute, Stockholm, Sweden.
Arch Public Health ; 80(1): 142, 2022 May 20.
Article em En | MEDLINE | ID: mdl-35590340
BACKGROUND: Injury remains a major concern to public health in the European region. Previous iterations of the Global Burden of Disease (GBD) study showed wide variation in injury death and disability adjusted life year (DALY) rates across Europe, indicating injury inequality gaps between sub-regions and countries. The objectives of this study were to: 1) compare GBD 2019 estimates on injury mortality and DALYs across European sub-regions and countries by cause-of-injury category and sex; 2) examine changes in injury DALY rates over a 20 year-period by cause-of-injury category, sub-region and country; and 3) assess inequalities in injury mortality and DALY rates across the countries. METHODS: We performed a secondary database descriptive study using the GBD 2019 results on injuries in 44 European countries from 2000 to 2019. Inequality in DALY rates between these countries was assessed by calculating the DALY rate ratio between the highest-ranking country and lowest-ranking country in each year. RESULTS: In 2019, in Eastern Europe 80 [95% uncertainty interval (UI): 71 to 89] people per 100,000 died from injuries; twice as high compared to Central Europe (38 injury deaths per 100,000; 95% UI 34 to 42) and three times as high compared to Western Europe (27 injury deaths per 100,000; 95%UI 25 to 28). The injury DALY rates showed less pronounced differences between Eastern (5129 DALYs per 100,000; 95% UI: 4547 to 5864), Central (2940 DALYs per 100,000; 95% UI: 2452 to 3546) and Western Europe (1782 DALYs per 100,000; 95% UI: 1523 to 2115). Injury DALY rate was lowest in Italy (1489 DALYs per 100,000) and highest in Ukraine (5553 DALYs per 100,000). The difference in injury DALY rates by country was larger for males compared to females. The DALY rate ratio was highest in 2005, with DALY rate in the lowest-ranking country (Russian Federation) 6.0 times higher compared to the highest-ranking country (Malta). After 2005, the DALY rate ratio between the lowest- and the highest-ranking country gradually decreased to 3.7 in 2019. CONCLUSIONS: Injury mortality and DALY rates were highest in Eastern Europe and lowest in Western Europe, although differences in injury DALY rates declined rapidly, particularly in the past decade. The injury DALY rate ratio of highest- and lowest-ranking country declined from 2005 onwards, indicating declining inequalities in injuries between European countries.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda